In this live, interactive webinar, leading pathology and oncology experts will help learners improve their knowledge, confidence, and competence with accurately performing pathological assessment, diagnosis, and evidence-based treatment strategies for patients with HER2-low or HER2-ultralow metastatic breast cancer.
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/events/pathologists-guide-to-her2-low-and-her2-ultralow-mbc/pathologists-guide-to-her2-low-and-her2-ultralow-mbc/16154-22604
- Start Date: 2025-03-25 05:00:00
- End Date: 2025-03-25 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- MOC Credit Details: ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
- Commercial Support: Source: AstraZeneca (Any division) - Amount: 62500.0 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 87500.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Breast, Clinical Pathology
Subscribe
Login
0 Comments
Oldest